SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015584
Filing Date
2022-08-08
Accepted
2022-08-08 16:42:27
Documents
75
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20220630.htm   iXBRL 10-Q 3886963
2 EX-10.1 stro-ex10_1.htm EX-10.1 64380
3 EX-10.2 stro-ex10_2.htm EX-10.2 1215167
4 EX-10.3 stro-ex10_3.htm EX-10.3 122438
5 EX-31.1 stro-ex31_1.htm EX-31.1 18877
6 EX-31.2 stro-ex31_2.htm EX-31.2 19027
7 EX-32.1 stro-ex32_1.htm EX-32.1 9575
8 EX-32.2 stro-ex32_2.htm EX-32.2 9605
  Complete submission text file 0000950170-22-015584.txt   14598680

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20220630.xsd EX-101.SCH 75548
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stro-20220630_def.xml EX-101.DEF 318835
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20220630_pre.xml EX-101.PRE 446304
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stro-20220630_cal.xml EX-101.CAL 47909
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20220630_lab.xml EX-101.LAB 575318
69 EXTRACTED XBRL INSTANCE DOCUMENT stro-20220630_htm.xml XML 2658594
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 221145036
SIC: 2836 Biological Products, (No Diagnostic Substances)